Pharmanex
This article was originally published in The Tan Sheet
Executive Summary
Cholestin marketer secures exclusive multi-level marketing channel rights to Policor policosanol under agreement with Hauser, firms announce Oct. 3. Hauser becomes sole supplier of beeswax-derived ingredient for use in Pharmanex' Cholestin, Cardio Formula supplements. Two days earlier, Hauser announced it exercised an option to purchase policosanol technology, intellectual property rights from an unidentified "developmental start-up company" for undisclosed terms. Hauser has manuyfactured Policor since February; Pharmanex debuted reformulated Cholestin in July after losing a lengthy court battle with FDA over use of red yeast rice in the product (1"The Tan Sheet" July 16, In Brief)
You may also be interested in...
Cholestin
New formulation contains Policor (policosanol), "beeswax-based" proprietary ingredient that inhibits cholesterol synthesis in liver, Pharmanex says July 9. NuSkin Enterprises division removed original red yeast rice-containing Cholestin from market following Utah federal court decision favoring FDA determination the product was a drug because it contained lovastatin, the active ingredient in Merck's Mevacor (1"The Tan Sheet" May 7, p. 15). Once-daily formula developed by Hauser replaces twice-daily red yeast rice dosage and is made with novel PoliSorb softgel delivery system. Thirty-count bottles marked "new and improved" are priced at $39.95
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands